REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 1st, 2024 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances
This Agreement is made pursuant to the Investment Agreement, dated as of January 8, 2024, between the Company and the Investor (as amended, amended and restated or otherwise modified from time to time, the “Investment Agreement”), pursuant to which the Company is selling to the Investor, and the Investor is purchasing from the Company, in each case on the Closing Date (as defined in the Investment Agreement), an aggregate of 56,342,355 shares (the “Shares”) of common stock, $0.001 par value of the Company (the “Common Stock”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 1st, 2024 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Perspective Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
